Yasuyuki Kobayashi Selected Research

Doxorubicin (Adriamycin)

8/2012	REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer.
4/2012	[A case of primary urotherial carcinoma with glandular differentiation of the renal pelvis with high serum level of carbohydrate antigen 19-9 (CA19-9)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyuki Kobayashi Research Topics

Disease

33	Neoplasms (Cancer) 12/2023 - 03/2004
14	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 07/2005
12	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 01/2007
11	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2010
10	Carcinoma (Carcinomatosis) 04/2024 - 08/2009
6	Infections 05/2023 - 04/2018
6	Inflammation (Inflammations) 07/2022 - 01/2010
6	Fibrosis (Cirrhosis) 01/2021 - 01/2009
5	Rheumatoid Arthritis 12/2018 - 07/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 02/2023 - 01/2005
4	Pathologic Constriction (Stenosis) 02/2023 - 08/2017
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023 - 04/2018
4	Hypertrophy 09/2022 - 01/2018
3	Heart Diseases (Heart Disease) 04/2024 - 01/2017
3	Heart Failure 06/2023 - 01/2021
3	Myocardial Infarction 06/2023 - 05/2004
3	Muscular Atrophy (Muscle Atrophy) 09/2022 - 07/2020
3	Disease Progression 01/2022 - 01/2019
3	Cystitis 12/2021 - 08/2016
3	Rectal Neoplasms (Rectal Cancer) 07/2021 - 08/2010
3	Ischemia 04/2021 - 01/2009
3	Urinary Incontinence 05/2019 - 01/2007
3	Testicular Neoplasms (Testicular Cancer) 02/2019 - 10/2013
3	Margins of Excision 01/2018 - 12/2008
3	Lymphatic Metastasis 11/2016 - 04/2012
2	Pneumonia (Pneumonitis) 01/2024 - 07/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 01/2021
2	Carcinoma in Situ 05/2023 - 02/2023
2	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 11/2013
2	Non-Muscle Invasive Bladder Neoplasms 02/2023 - 06/2018
2	Hypoxia (Hypoxemia) 09/2022 - 04/2021
2	Urinary Tract Infections (Urinary Tract Infection) 07/2022 - 04/2019
2	Hypoplastic Left Heart Syndrome 01/2022 - 10/2021
2	Epididymitis 12/2021 - 04/2017
2	Prostatitis 12/2021 - 02/2008
2	Myocarditis (Carditis) 09/2021 - 01/2016
2	Hypertension (High Blood Pressure) 01/2021 - 01/2021
2	Non-alcoholic Fatty Liver Disease 12/2020 - 01/2020
2	Hypersensitivity (Allergy) 06/2020 - 01/2017
2	Hemorrhage 02/2019 - 12/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 04/2018
2	Chronic Renal Insufficiency 01/2018 - 01/2015
2	Pain (Aches) 10/2017 - 02/2008

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 04/2012
6	GadoliniumIBA 01/2021 - 09/2013
5	Proteins (Proteins, Gene)FDA Link 05/2023 - 12/2010
5	Gemcitabine FDA Link 10/2021 - 01/2010
5	Prostate-Specific Antigen (Semenogelase)IBA 07/2012 - 07/2005
4	CreatinineIBA 07/2021 - 11/2006
4	Paclitaxel (Taxol)FDA LinkGeneric 06/2016 - 01/2010
4	Carboplatin (JM8)FDA LinkGeneric 02/2016 - 04/2012
3	Interleukin-6 (Interleukin 6)IBA 02/2024 - 10/2014
3	AndrogensIBA 02/2024 - 12/2007
3	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2022
3	Messenger RNA (mRNA)IBA 11/2022 - 07/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 08/2006
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 10/2013
3	tocilizumab (atlizumab)FDA Link 12/2018 - 10/2014
3	Etoposide (VP 16)FDA LinkGeneric 04/2018 - 10/2013
3	Methotrexate (Mexate)FDA LinkGeneric 07/2014 - 04/2012
2	pembrolizumabIBA 04/2024 - 12/2023
2	Clostridium perfringens epsilon-toxinIBA 04/2024 - 12/2021
2	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 11/2020
2	SteroidsIBA 01/2024 - 02/2021
2	Immune Checkpoint InhibitorsIBA 11/2023 - 11/2020
2	EnzymesIBA 01/2023 - 02/2021
2	Carotenoids (Carotene)IBA 09/2022 - 01/2020
2	oleylamide (oleamide)IBA 07/2022 - 01/2021
2	NivolumabIBA 01/2022 - 06/2021
2	Iodine-125IBA 12/2021 - 02/2008
2	Rituximab (Mabthera)FDA Link 12/2020 - 04/2019
2	IceIBA 10/2020 - 11/2006
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 06/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2019 - 01/2017
2	C-Reactive ProteinIBA 01/2019 - 01/2011
2	Capsules (Microcapsules)IBA 03/2018 - 01/2007

Therapy/Procedure

26	Therapeutics 02/2024 - 05/2004
16	Drug Therapy (Chemotherapy) 01/2023 - 08/2010
9	Prostatectomy (Retropubic Prostatectomy) 04/2020 - 01/2007
8	Nephroureterectomy 10/2023 - 08/2009
7	Nephrectomy 01/2022 - 01/2007
6	Radiotherapy 12/2023 - 08/2010
4	Brachytherapy 12/2021 - 12/2007
3	Cardiac Rehabilitation 06/2023 - 01/2021
3	Kidney Transplantation 01/2022 - 12/2020
3	Cryosurgery 10/2020 - 04/2017
3	Orchiectomy (Orchidectomy) 04/2017 - 10/2013
3	Adjuvant Chemotherapy 06/2016 - 01/2005
3	Cystectomy 06/2016 - 08/2009
2	Immunotherapy 12/2023 - 02/2023
2	Patient Readmission 06/2023 - 06/2023
2	Catheters 05/2023 - 12/2014
2	Lymph Node Excision (Lymph Node Dissection) 11/2022 - 01/2007
2	Blalock-Taussig Procedure 01/2022 - 01/2022
2	Colostomy 07/2021 - 08/2010
2	Renal Dialysis (Hemodialysis) 07/2021 - 01/2010
2	Endovascular Aneurysm Repair 02/2019 - 08/2014
2	Intravesical Administration 06/2018 - 08/2012
2	Transurethral Resection of Bladder 06/2018 - 01/2005
2	Oral Administration 01/2018 - 04/2017